Connect with us

Business

Why Oxford’s Covid-19 vaccine could do more for the world than other shots – CNN

In the days since Oxford University and AstraZeneca unveiled the results of the partnership’s Phase 3 Covid-19 vaccine trials, a growing number of questions have…

Published

on

post featured image
ADVERTISEMENT

London (CNN)In the days since Oxford University and AstraZeneca unveiled the results of the partnership’s Phase 3 Covid-19 vaccine trials, a growing number of questions have emerged.
The stated 70% average efficacy was significantly lower than the 94.5% to 95% reported by the other two leading candidates, Moderna and Pfizer.
Yet this vaccine could still prove to be more valuable for the world than the other two in the coming months. If the questions over its results are answered and it receives…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

post featured image
Department store chain Belk filing for Chapter 11 bankruptcy – Fox Business
post featured image
E.U. and U.K. Fight Over Coronavirus Vaccines: ‘Solidarity Is Failing’ – The New York Times
post featured image
Ant Group IPO could get back on track if it resolves issues, China’s central bank governor suggests – CNBC